A surface modified implant or a part thereof comprising a first drug is an anti-proliferative drug, and a second drug is a non-polymeric lipophilic agent. The release of the first drug is controlled by the second drug. The first and second drugs are sprayed on the surface modified implant or a part thereof. A pre-sp...